Fritz Melchers
Corporate Officer/Principal bij University of Basel
Profiel
Dr. Fritz Melchers is a Director-Executive Board & Co-Founder at 4-Antibody AG and a Professor at University of Basel.
Dr. Melchers was previously employed as a Principal by Max-Planck-Institute for Molecular Genetics and a Principal by The Salk Institute for Biological Studies.
Actieve functies van Fritz Melchers
| Bedrijven | Functie | Begin |
|---|---|---|
| University of Basel | Corporate Officer/Principal | 21-04-2010 |
Eerdere bekende functies van Fritz Melchers
| Bedrijven | Functie | Einde |
|---|---|---|
| The Salk Institute for Biological Studies | Corporate Officer/Principal | - |
| Max-Planck-Institute for Molecular Genetics | Corporate Officer/Principal | - |
4-Antibody AG
 4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Health Technology |
